
Novel Molecules Private Limited
This company specializes in the production and distribution of various chemicals, including agricultural and industrial products.
This company specializes in the production and distribution of various chemicals, including agricultural and industrial products.
Novel Molecules Private Limited (NMPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2019 (Five years and five months 20 days old ). Its registered office is in Ratnagiri, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.98 M.
Pradeep Mulaokar and Sahil Mulaokar serve as directors at the Company.
Ratnagiri, Maharashtra, India
+91-XXXXXXXXXX
U24297PN2019PTC188316
188316
Private Limited Indian Non-Government Company
10 Dec 2019
30 Sep 2024
31 Mar 2024
Unlisted
Roc Pune
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sahil Mulaokar ![]() | Director | 10-Dec-2019 | Current |
Pradeep Mulaokar ![]() | Additional Director | 14-Aug-2021 | Current |
Novel Molecules Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 166.79% increase. The company also saw a substantial improvement in profitability, with a 392.68% increase in profit. The company's net worth Soared by an impressive increase of 200.48%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Novel Molecules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Pradeep Mulaokar is a mutual person
Pradeep Mulaokar and Sahil Mulaokar are mutual person
Pradeep Mulaokar and Sahil Mulaokar are mutual person
₹2.98 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
05 Oct 2021 | Others | ₹1.80 M | Open |
07 Sep 2021 | Others | ₹1.18 M | Open |
Unlock and access historical data on people associated with Novel Molecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novel Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novel Molecules's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Novel Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Novel Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
A charge with Others amounted to Rs. 1.80 M with Charge ID 100502702 was registered on 05 Oct 2021.
A charge with Others amounted to Rs. 1.18 M with Charge ID 100484026 was registered on 07 Sep 2021.
Pradeep Digamber Mulaokar was appointed as a Additional Director was appointed as a Additional Director on 14 Aug 2021 & has been associated with this company since 3 years 9 months .
Sahil Pradeep Mulaokar was appointed as a Director was appointed as a Director on 10 Dec 2019 & has been associated with this company since 5 years 5 months .
Novel Molecules Private Limited was incorporated on 10 Dec 2019.
The authorized share capital of Novel Molecules Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Novel Molecules Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Novel Molecules Private Limited is Plot No. B-45 Midc Lote Parshuram, India, Khed, Maharashtra, 415722.
The corporate identification number (CIN) of Novel Molecules Private Limited is U24297PN2019PTC188316 and the company number is 188316 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Novel Molecules Private Limited has risen by 166.79%.
The financial reports for the fiscal year 2022 indicates that The net worth of Novel Molecules Private Limited has experienced an upsurge of 200.48%.
As per the financial statements for fiscal Year 2022, The total open charges for Novel Molecules Private Limited amount to ₹ 2.98 M.
The most recent Balance Sheet for Novel Molecules Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
SS